American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1965)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (5)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1362)

Results (4047)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IL-1β pathway promotes cell proliferation and 5-FU resistance in African American colon cancer cell lines
    Meeting Abstract

    Spagnardi, M.; Paredes, J.; Garai, J.; Zabaleta, J.; Williams, J.; Martello-Rooney, L.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers
    Meeting Abstract

    Rothwell, D. G.; Chemi, F.; Pearce, S.; Clipson, A.; Hill, S.; Conway, A. M.; Richardson, S.; Murat, K.; Caeser, R.; Egger, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromosomal instability shapes the tumor microenvironment through a chronic ER-stress response
    Meeting Abstract

    Li, J.; Hubisz, M.; Earlie, E.; Duran, M. A.; Lettera, E.; Phyu, S. M.; Amin, A. D.; Deyell, M.; Kamiya, E.; Budre, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Organic anion transporter(SLCO)genotype and prostate cancer progression: Prospective cohort study and meta-analysis
    Meeting Abstract

    Stopsack, K. H.; Rajanala, H.; Plym, A.; Vaselkiv, J. B.; Matsoukas, K.; Ebot, E. M.; Markt, S. C.; Penney, K. L.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • TERT mutant promoter mouse model induces cancer progression in Braf(V600E)-driven thyroid tumors: A novel tool to understand the biology of telomerase-reactivated cancers
    Meeting Abstract

    Landa, I.; Hao, J. Z.; Xu, B.; Giacalone, J.; Herbert, Z.; Blasco, M. A.; Knauf, J. A.; Ghossein, R.; Fagin, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Curating cartography: Enabling the harmonisation, visualisation, and reuse of diverse multiplexed imaging data through the Human Tumor Atlas Network Data Coordinating Center
    Meeting Abstract

    Taylor, A. J.; Nikolov, M.; de Brujin, I.; Muhlich, J.; De Felice, M.; Sokolov, A.; Schapiro, D.; Sorger, P.; Bletz, J.; Schultz, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Oldridge, D. A.; Wellhausen, N.; Greenplate, A. R.; Chilukuri, L.; Mathew, D.; Xu, C.; Herati, R. S.; Huang, A. C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Meeting Abstract

    Singh, K.; Mohan, P.; Sanghvi, V. R.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: